Status: Open Not Enrolling
Investigator: Terry Clyburn
Study Coordinator: Adrienne New
Phone: 713.441.3250
This study is designed to observe the long term clinical outcomes of patient-specific knee arthroplasty in patients with osteoarthritis. ... Read more >
Status: Open Not Enrolling
Investigator: Lisa Kopas
Study Coordinator: Jessica Garcia
Phone: 713.255.4095
The purpose of this research is to study a medical device that is designed to produce lung volume reduction. This device is called the PulmonX Endobronchial Valve (EBV). It has not been approved by the Food and Drug Administration (FDA) and is c ... Read more >
Status: Enrolling
Investigator: Ahmed Gaber
Study Coordinator: Alejandro De La Torre
Phone: 713.441.6396
Rabbit antithymocyte globulin (rATG) is approved for the treatment of acute rejection following kidney transplantation and is routinely administered as a series of 5-7 consecutive daily doses via central intravenous catheter. This prolonged cour ... Read more >
Status: Enrolling
Investigator: Maen Abdelrahim
Study Coordinator: Michelle Guthrie
Phone: 713.441.6564
RPL-001-16 is a Phase 1/2, open label, dose escalation and expansion clinical study of RP1 alone and in combination with nivolumab in adult subjects with advanced and/or refractory solid tumors, to determine the maximum tolerated dose (MTD) and ... Read more >
